Insulin and carbohydrate metabolism

Best Practice and Research in Clinical Endocrinology and Metabolism

Volumn 22, Issue 1, 2008, Pages 41-55

  Beardsall, Kathryn ^a   Diderholm, Barbro M S ^a,b   Dunger, David B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY CHILDREN S HOSPITAL   (Sweden)

Author keywords

diabetes; glucose; growth; insulin; neonate; pregnancy

Indexed keywords

CARBOHYDRATE; GLUCOSE; HYPERGLYCEMIC AGENT; INOTROPIC AGENT; INSULIN; INSULIN DERIVATIVE; SOMATOMEDIN C; STEROID;

CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASE; CONGENITAL MALFORMATION; CONTINUOUS INFUSION; FETUS GROWTH; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN METABOLISM; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LARGE FOR GESTATIONAL AGE; NECROTIZING ENTEROCOLITIS; NEWBORN INTENSIVE CARE; NEWBORN SEPSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POSTNATAL GROWTH; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURITY; REVIEW; SMALL FOR DATE INFANT; SPONTANEOUS ABORTION;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; FETAL MACROSOMIA; GLUCOSE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN; PREGNANCY;

EID: 38949165952     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2007.10.001     Document Type: Review

References (120)

1. Economides D.L., Proudler A., and Nicolaides K.H. Plasma insulin in appropriate- and small-for-gestational-age fetuses. American Journal of Obstetrics and Gynecology 160 (1989) 1091-1094
2. Hill D.J., Petrik J., and Arany E. Growth factors and the regulation of fetal growth. Diabetes Care 21 supplement 2 (1998) B60-B69
3. Hill D.J., and Duvillie B. Pancreatic development and adult diabetes. Pediatric Research 48 (2000) 269-274
4. Hay Jr. W.W., and Sparks J.W. Placental, fetal, and neonatal carbohydrate metabolism. Clinical Obstetrics and Gynecology 28 (1985) 473-485
5. Ong K., Kratzsch J., Kiess W., et al. Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. The Journal of Clinical Endocrinology and Metabolism 85 (2000) 4266-4269
6. Kliegman R.M. Intrauterine Growth Retardation. In: Fanaroff A.A., and Martin R.J. (Eds). Neonatal-perinatal medicine:diseases of the fetus and neonate. 6 edn (1997), Mosby, St. Louis, Mo 203-240
7. Kalhan S.C., D'Angelo L.J., Savin S.M., et al. Glucose production in pregnant women at term gestation. Sources of glucose for human fetus. Journal of Clinical Investigation 63 (1979) 388-394
8. Catalano P.M., Tyzbir E.D., Wolfe R.R., et al. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. American Journal of Physiology 264 (1993) E60-E67
9. Boden G. Fuel metabolism in pregnancy and in gestational diabetes mellitus. Obstetrics and Gynecology Clinics of North America 23 (1996) 1-10
10. Kalhan S., Rossi K., Gruca L., et al. Glucose turnover and gluconeogenesis in human pregnancy. Journal of Clinical Investigation 100 (1997) 1775-1781
11. Illsley N.P. Glucose transporters in the human placenta. Placenta 21 (2000) 14-22
12. Hay Jr. W.W., and Meznarich H.K. Effect of maternal glucose concentration on uteroplacental glucose consumption and transfer in pregnant sheep. Proceedings of the Society for Experimental Biology and Medicine 190 (1989) 63-69
13. Gaither K., Quraishi A.N., and Illsley N.P. Diabetes alters the expression and activity of the human placental GLUT1 glucose transporter. Journal of Clinical Endocrinology and Metabolism 84 (1999) 695-701
14. Esterman A., Greco M.A., Mitani Y., et al. The effect of hypoxia on human trophoblast in culture: morphology, glucose transport and metabolism. Placenta 18 (1997) 129-136
15. Hahn T., Barth S., Graf R., et al. Placental glucose transporter expression is regulated by glucocorticoids. The Journal of Clinical Endocrinology and Metabolism 84 (1999) 1445-1452
16. Hay Jr. W.W., Meznarich H.K., DiGiacomo J.E., et al. Effects of insulin and glucose concentrations on glucose utilization in fetal sheep. Pediatric Research 23 (1988) 381-387
17. Ostlund I., Hanson U., Bjorklund A., et al. Maternal and fetal outcomes if gestational impaired glucose tolerance is not treated. Diabetes Care 26 (2003) 2107-2111
18. Metzger B.E., and Coustan D.R. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 21 supplement 2 (1998) B161-B167
19. Crowther C.A., Hiller J.E., Moss J.R., et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. The New England Journal of Medicine 352 (2005) 2477-2486
20. Chen R., Yogev Y., Ben-Haroush A., et al. Continuous glucose monitoring for the evaluation and improved control of gestational diabetes mellitus. The Journal of Maternal-Fetal and Neonatal Medicine 14 (2003) 256-260
21. Yogev Y., Chen R., Ben-Haroush A., et al. Continuous glucose monitoring for the evaluation of gravid women with type 1 diabetes mellitus. Obstetrics and Gynecology 101 (2003) 633-638
22. Buhling K.J., Winkel T., Wolf C., et al. Optimal timing for postprandial glucose measurement in pregnant women with diabetes and a non-diabetic pregnant population evaluated by the Continuous Glucose Monitoring System (CGMS). Journal of Perinatal Medicine 33 (2005) 125-131
23. Murphy H., Rayman G., Duffield K., et al. Changes in the glycaemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care 30 (2007) 2785-2791
24. Ben-Haroush A., Yogev Y., Chen R., et al. The postprandial glucose profile in the diabetic pregnancy. American Journal of Obstetrics and Gynecology 191 (2004) 576-581
25. Yogev Y., Ben-Haroush A., Chen R., et al. Diurnal glycemic profile in obese and normal weight nondiabetic pregnant women. American Journal of Obstetrics and Gynecology 191 (2004) 949-953
26. Jovanovic-Peterson L., Peterson C.M., Reed G.F., et al. Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development-Diabetes in Early Pregnancy Study. American Journal of Obstetrics and Gynecology 164 (1991) 103-111
27. Kitzmiller J.L., Buchanan T.A., Kjos S., et al. Pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care 19 (1996) 514-541
28. Moore L.L., Singer M.R., Bradlee M.L., et al. A prospective study of the risk of congenital defects associated with maternal obesity and diabetes mellitus. Epidemiology 11 (2000) 689-694
29. Gabbe S.G., and Graves C.R. Management of diabetes mellitus complicating pregnancy. Obstetrics and Gynecology 102 (2003) 857-868
30. Lauenborg J., Mathiesen E., Ovesen P., et al. Audit on stillbirths in women with pregestational type 1 diabetes. Diabetes Care 26 (2003) 1385-1389
31. Ryan E.A., and Enns L. Role of gestational hormones in the induction of insulin resistance. Journal of Clinical Endocrinology and Metabolism 67 (1988) 341-347
32. Catalano P.M., Kirwan J.P., Haugel-de Mouzon S., et al. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. Journal of Nutrition 133 (2003) 1674S-1683S
33. Ktorza A., Bihoreau M.T., Nurjhan N., et al. Insulin and glucagon during the perinatal period: secretion and metabolic effects on the liver. Biology of the Neonate 48 (1985) 204-220
34. Fowden A.L., Hughes P., and Comline R.S. The effects of insulin on the growth rate of the sheep fetus during late gestation. Quarterly Journal of Experimental Physiology 74 (1989) 703-714
35. Oliver M.H., Harding J.E., Breier B.H., et al. Fetal insulin-like growth factor (IGF)-I and IGF-II are regulated differently by glucose or insulin in the sheep fetus. Reproduction Fertility and Development 8 (1996) 167-172
36. Lampl M., and Jeanty P. Exposure to maternal diabetes is associated with altered fetal growth patterns: A hypothesis regarding metabolic allocation to growth under hyperglycemic-hypoxemic conditions. American Journal of Human Biology 16 (2004) 237-263
37. Homko C.J., and Reece E.A. Insulins and oral hypoglycemic agents in pregnancy. The Journal of Maternal-Fetal and Neonatal Medicine 19 (2006) 679-686
38. Gimenez M., Conget I., Nicolau J., et al. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study. Acta Diabetologica 44 (2007) 34-37
39. Lashen H., Fear K., and Sturdee D.W. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Human Reproduction 19 (2004) 1644-1646
40. Kristensen J., Vestergaard M., Wisborg K., et al. Pre-pregnancy weight and the risk of stillbirth and neonatal death. BJOG 112 (2005) 403-408
41. Orskou J., Henriksen T.B., Kesmodel U., et al. Maternal characteristics and lifestyle factors and the risk of delivering high birth weight infants. Obstetrics and Gynecology 102 (2003) 115-120
42. Surkan P.J., Hsieh C.C., Johansson A.L., et al. Reasons for increasing trends in large for gestational age births. Obstetrics and Gynecology 104 (2004) 720-726
43. Waller D.K., Mills J.L., Simpson J.L., et al. Are obese women at higher risk for producing malformed offspring?. American Journal of Obstetrics and Gynecology 170 (1994) 541-548
44. Cedergren M.I., and Kallen B.A. Maternal obesity and infant heart defects. Obesity Research 11 (2003) 1065-1071
45. Volcik K.A., Shaw G.M., Zhu H., et al. Risk factors for neural tube defects: associations between uncoupling protein 2 polymorphisms and spina bifida. Birth Defects Research. Part A, Clinical and Molecular Teratology 67 (2003) 158-161
46. Volcik K.A., Shaw G.M., Zhu H., et al. Associations between polymorphisms within the thymidylate synthase gene and spina bifida. Birth Defects Research. Part A, Clinical and Molecular Teratology 67 (2003) 924-928
47. Huang D.Y., Usher R.H., Kramer M.S., et al. Determinants of unexplained antepartum fetal deaths. Obstetrics and Gynecology 95 (2000) 215-221
48. Nohr E.A., Bech B.H., Davies M.J., et al. Prepregnancy obesity and fetal death: a study within the Danish National Birth Cohort. Obstetrics and Gynecology 106 (2005) 250-259
49. Weiss J.L., Malone F.D., Emig D., et al. Obesity, obstetric complications and cesarean delivery rate-a population-based screening study. American Journal of Obstetrics and Gynecology 190 (2004) 1091-1097
50. Sivan E., Chen X., Homko C.J., et al. Longitudinal study of carbohydrate metabolism in healthy obese pregnant women. Diabetes Care 20 (1997) 1470-1475
51. Catalano P.M., Huston L., Amini S.B., et al. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. American Journal of Obstetrics and Gynecology 180 (1999) 903-916
52. Butte N.F. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. American Journal of Clinical Nutrition 71 (2000) 1256S-1261S
53. Langer O., Yogev Y., Xenakis E.M., et al. Overweight and obese in gestational diabetes: the impact on pregnancy outcome. American Journal of Obstetrics and Gynecology 192 (2005) 1768-1776
54. Metzger B.E. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. International Journal of Gynaecology and Obstetrics 78 (2002) 69-77
55. Economides D.L., and Nicolaides K.H. Blood glucose and oxygen tension levels in small-for-gestational-age fetuses. American Journal of Obstetrics and Gynecology 160 (1989) 385-389
56. Sperling M.A., DeLamater P.V., Phelps D., et al. Spontaneous and amino acid-stimulated glucagon secretion in the immediate postnatal period. Relation to glucose and insulin. The Journal of Clinical Investigation 53 (1974) 1159-1166
57. Sperling M.A., Ganguli S., Leslie N., et al. Fetal-perinatal catecholamine secretion: role in perinatal glucose homeostasis. American Journal of Psychology 247 (1984) E69-E74
58. Girard J.R., Caquet D., Bal D., et al. Control of rat liver phosphorylase, glucose-6-phosphatase and phosphoenolpyruvate carboxykinase activities by insulin and glucagon during the perinatal period. Enzyme 15 (1973) 272-285
59. Hume R., and Burchell A. Abnormal expression of glucose-6-phosphatase in preterm infants. Archives of Disease in Childhood 68 (1993) 202-204
60. Marcus C., Ehren H., Bolme P., et al. Regulation of lipolysis during the neonatal period. Importance of thyrotropin. The Journal of Clinical Investigation 82 (1988) 1793-1797
61. Lucas A., Bloom S.R., and Aynsley-Green A. Metabolic and endocrine events at the time of the first feed of human milk in preterm and term infants. Archives of Disease in Childhood 53 (1978) 731-736
62. Scaglia L., Cahill C.J., Finegood D.T., et al. Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 138 (1997) 1736-1741
63. Petrik J., Arany E., McDonald T.J., et al. Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor. Endocrinology 139 (1998) 2994-3004
64. Petrik J., Pell J.M., Arany E., et al. Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia. Endocrinology 140 (1999) 2353-2363
65. Kassem S.A., Ariel I., Thornton P.S., et al. Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 49 (2000) 1325-1333
66. Catalano P.M., Drago N.M., and Amini S.B. Maternal carbohydrate metabolism and its relationship to fetal growth and body composition. American Journal of Obstetrics and Gynecology 172 (1995) 1464-1470
67. Artal R., Doug N., Wu P., et al. Circulating catecholamines and glucagon in infants of strictly controlled diabetic mothers. Biology of the Neonate 53 (1988) 121-125
68. Sunehag A., Ewald U., Larsson A., et al. Attenuated hepatic glucose production but unimpaired lipolysis in newborn infants of mothers with diabetes. Pediatric Research 42 (1997) 492-497
69. Lagercrantz H., and Bistoletti P. Catecholamine release in the newborn infant at birth. Pediatric Research 11 (1977) 889-893
70. Akinbi H.T., and Gerdes J.S. Macrosomic infants of nondiabetic mothers and elevated C-peptide levels in cord blood. The Journal of Pediatrics 127 (1995) 481-484
71. Schaefer-Graf U.M., Rossi R., Buhrer C., et al. Rate and risk factors of hypoglycemia in large-for-gestational-age newborn infants of nondiabetic mothers. American Journal of Obstetrics and Gynecology 187 (2002) 913-917
72. Ahlsson F., Diderholm B., Ewald U., et al. Lipolysis and Insulin Sensitivity at Birth in Infants Who are Large for Gestational Age. Pediatrics 120 (2007) 958-965
73. Hawdon J., and Ward Platt M. Metabolic adaption in small for gestational age infants. Archives of Disease in Childhood 68 (1993) 262-268
74. Garofano A., Czernichow P., and Breant B. In utero undernutrition impairs rat beta-cell development. Diabetologia 40 (1997) 1231-1234
75. Van Assche F.A., De Prins F., Aerts L., et al. The endocrine pancreas in small-for-dates infants. British Journal of Obstetrics and Gynaecology 84 (1977) 751-753
76. Beringue F., Blondeau B., Castellotti M.C., et al. Endocrine pancreas development in growth-retarded human fetuses. Diabetes 51 (2002) 385-391
77. Limesand S.W., Jensen J., Hutton J.C., et al. Diminished beta-cell replication contributes to reduced beta-cell mass in fetal sheep with intrauterine growth restriction. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 288 (2005) R1297-R1305
78. Dahri S., Snoeck A., Reusens-Billen B., et al. Islet function in offspring of mothers on low protein diet during gestation. Diabetes 40 (1991) 115-120
79. Setia S., Sridhar M.G., Bhat V., et al. Insulin sensitivity and insulin secretion at birth in intrauterine growth retarded infants. Pathology 38 (2006) 236-238
80. Bazaes R.A., Salazar T.E., Pittaluga E., et al. Glucose and lipid metabolism in small for gestational age infants at 48 hours of age. Pediatrics 111 (2003) 804-809
81. Wang X., Cui Y., Tong X., et al. Glucose and lipid metabolism in small-for-gestational-age infants at 72 hours of age. The Journal of Clinical Endocrinology and Metabolism 92 (2007) 681-684
82. Ogilvy-Stuart A.L., Hands S.J., Adcock C.J., et al. Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn. The Journal of Clinical Endocrinology and Metabolism 83 (1998) 3550-3557
83. Keshen T., Miller R., Jahoor F., et al. Glucose production and gluconeogenesis are negatively related to body weight in mechanically ventilated, very low birth weight neonates. Pediatric Research 41 1 (1997 Jan) 132-138
84. Hawdon J.M., Ward Platt M.P., and Aynsley-Green A. Patterns of metabolic adaptation for preterm and term infants in the first neonatal week. Archives of Disease in Childhood 67 (1992) 357-365
85. Haymond M.W., Karl I.E., and Pagliara A.S. Increased gluconeogenic substrates in the small-for-gestational-age infant. The New England Journal of Medicine 291 (1974) 322-328
86. Van Kempen A.A., Romijn J.A., Ruiter A.F., et al. Adaptation of glucose production and gluconeogenesis to diminishing glucose infusion in preterm infants at varying gestational ages. Pediatric Research 53 (2003) 628-634
87. Beardsall K., Ogilvy-Stuart A.L., Ahluwalia J., et al. The continuous glucose monitoring sensor in neonatal intensive care. Archives of Disease in Childhood. Fetal and Neonatal Edition 90 (2005) F307-F310
88. Hawdon J.M., Aynsley-Green A., Alberti K.G., et al. The role of pancreatic insulin secretion in neonatal glucoregulation. I. Healthy term and preterm infants. Archives of Disease in Childhood 68 (1993) 274-279
89. Mitanchez-Mokhtari D., Lahlou N., Kieffer F., et al. Both relative insulin resistance and defective islet beta-cell processing of proinsulin are responsible for transient hyperglycemia in extremely preterm infants. Pediatrics 113 (2004) 537-541
90. Aynsley-Green A. The endocrinology of feeding in the newborn. Baillière's Clinical Endocrinology and Metabolism 3 (1989) 837-868
91. Baggio L.L., and Drucker D.J. Biology of incretins: GLP-1 and GIP. Gastroenterology 132 (2007) 2131-2157
92. Farrag H.M., Nawrath L.M., Healey J.E., et al. Persistent glucose production and greater peripheral sensitivity to insulin in the neonate vs. the adult. American Journal of Psychology 272 (1997) E86-E93
93. Goldman S.L., and Hirata T. Attenuated response to insulin in very low birthweight infants. Pediatric Research 14 (1980) 50-53
94. Ogata E.S. Carbohydrate Homeostasis. In: Avery G.B., Fletcher M.A., and MacDonald M.G. (Eds). Neonatology Pathophysiology and Management of the Newborn. 5 edn (1999), Lippincott Williams&Wilkins, Philadelphia 699-714
95. Hey E. Hyperglycaemia and the very preterm baby. Seminars in Fetal and Neonatal Medicine 10 (2005) 377-387
96. McCowen K.C., Malhotra A., and Bistrian B.R. Stress-induced hyperglycemia. Critical Care Clinics 17 (2001) 107-124
97. Latham R., Lancaster A.D., Covington J.F., et al. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infection Control and Hospital Epidemiology 22 (2001) 607-612
98. Guvener M., Pasaoglu I., Demircin M., et al. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocrine Journal 49 (2002) 531-537
99. Gore D.C., Chinkes D., Heggers J., et al. Association of hyperglycemia with increased mortality after severe burn injury. The Journal of Trauma 51 (2001) 540-544
100. Finberg L. Dangers to infants caused by changes in osmolal concentration. Pediatrics 40 (1967) 1031-1034
101. Hays S.P., Smith E.O., and Sunehag A.L. Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants. Pediatrics 118 (2006) 1811-1818
102. Kao L.S., Morris B.H., Lally K.P., et al. Hyperglycemia and morbidity and mortality in extremely low birth weight infants. Journal of Perinatology (2006)
103. Beardsall K., Ogilvy-Stuart A.L., Frystyk J., et al. Early elective insulin therapy can reduce hyperglycemia and increase insulin-like growth factor-I levels in very low birth weight infants. The Journal of Pediatrics 151 (2007) 611-617
104. Collins J.W., Hoppe M., Brown K., et al. A controlled trial of insulin infusion and parentral nutrition in extremely low birth weight infants with glucose intolerance. The Journal of Pediatrics 118 (1991) 921-927
105. Meetze W., Bowsher R., Compton J., et al. hyperglycaemia in extremely-low birth weight infants. Biology of the Neonate 74 (1998) 214-221
106. Hellström A., Engström E., Hård A.L., et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 112 5 (2003 Nov) 1016-1020
107. Sobngwi E., Boudou P., Mauvais-Jarvis F., et al. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet 361 (2003) 1861-1865
108. Hunter W.A., Cundy T., Rabone D., et al. Insulin sensitivity in the offspring of women with type 1 and type 2 diabetes. Diabetes Care 27 (2004) 1148-1152
109. Pettitt D.J., Bennett P.H., Saad M.F., et al. Abnormal glucose tolerance during pregnancy in Pima Indian women. Long-term effects on offspring. Diabetes 40 supplement 2 (1991) 126-130
110. Dabelea D., Hanson R.L., Lindsay R.S., et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 49 (2000) 2208-2211
111. Ekelund U., Ong K.K., Linne Y., et al. Association of Weight Gain in Infancy and Early Childhood with Metabolic Risk in Young Adults. The Journal of Clinical Endocrinology and Metabolism 92 (2007) 98-103
112. Li H., Stein A.D., Barnhart H.X., et al. Associations between prenatal and postnatal growth and adult body size and composition. American Journal of Clinical Nutrition 77 (2003) 1498-1505
113. Franks P.W., Looker H.C., Kobes S., et al. Gestational glucose tolerance and risk of type 2 diabetes in young Pima Indian offspring. Diabetes 55 (2006) 460-465
114. Hales C.N., Barker D.J., Clark P.M., et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 303 (1991) 1019-1022
115. Hofman P.L., Regan F., Jackson W.E., et al. Premature birth and later insulin resistance. The New England Journal of Medicine 351 (2004) 2179-2186
116. Uthaya S., Thomas E.L., Hamilton G., et al. Altered adiposity after extremely preterm birth. Pediatric Research 57 (2005) 211-215
117. Yau K.I., and Chang M.H. Growth and body composition of preterm, small-for-gestational-age infants at a postmenstrual age of 37-40 weeks. Early Human Development 33 (1993) 117-131
118. Bazaes R.A., Alegria A., Pittaluga E., et al. Determinants of insulin sensitivity and secretion in very-low-birth-weight children. The Journal of Clinical Endocrinology and Metabolism 89 (2004) 1267-1272
119. Victora C.G., Barros F.C., Horta B.L., et al. Short-term benefits of catch-up growth for small-for-gestational-age infants. International Journal of Epidemiology 30 (2001) 1325-1330
120. Lucas A., Morley R., and Cole T.J. Randomised trial of early diet in preterm babies and later intelligence quotient. BMJ 317 (1998) 1481-1487